drugset / Trial / NCT03477448

The Efficacy of Intra-lesional Bleomycin Versus Intra-lesional Purified Protein Derivative in Treatment of Palmoplantar Warts

NCT03477448

Phase 4 Unknown 40 enrolled Assiut University
RandomizedParallel-groupOpen-labelScreening

Summary

* Warts are common viral infections on the skin and are prevalent worldwide. Warts are caused by the human Papilloma virus (HPV), which has more than 100 strains; some of them are known to be premalignant. Although warts can appear at any age, they are more common in children and adolescents. The prognosis of warts cannot be predicted. In some patients they may spontaneously disappear, whereas others show persistence and progression with spreading to other body sites, leading to physical and emotional distress to the patients. * Factors that increase the risk include use of public showers, working with meat, eczema, and a low immune system . The virus is believed to enter the body through skin that has been damaged slightly . A number of types exist including: common warts, plantar warts, filiform warts, and genital warts . Genital warts are often sexually transmitted.

Timeline

Start
2018-04-01
Primary completion
2019-04-01
Completion
2020-04-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bleomycin Unknown Other
Comparator tuberculin Diagnostic / imaging agent 10 iu Other

Indications